Further evaluation of COMPACT, the molecular orbital approach for the prospective safety evaluation of chemicals.

[1]  D. Lewis,et al.  Molecular modelling of CYP2E1 enzymes from rat, mouse and man: an explanation for species differences in butadiene metabolism and potential carcinogenicity, and rationalization of CYP2E substrate specificity. , 1997, Toxicology.

[2]  D F Lewis,et al.  A retrospective evaluation of COMPACT predictions of the outcome of NTP rodent carcinogenicity testing. , 1995, Environmental health perspectives.

[3]  D. Parke,et al.  The cytochromes P450 and mechanisms of chemical carcinogenesis. , 1994, Environmental health perspectives.

[4]  D. Parke,et al.  Computer modelling in predicting carcinogenicity. , 1993, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[5]  J. Ashby,et al.  The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures. , 1993, Mutation research.

[6]  D. Lewis,et al.  Validation of a novel molecular orbital approach (COMPACT) for the prospective safety evaluation of chemicals, by comparison with rodent carcinogenicity and Salmonella mutagenicity data evaluated by the U.S. NCI/NTP. , 1993, Mutation research.

[7]  D. Lewis,et al.  Antimutagenicity of ellagic acid towards the food mutagen IQ: investigation into possible mechanisms of action. , 1992, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[8]  Gisela Wits.  Active Oxygen Species as Factors in Multistage Carcinogenesis , 1991 .

[9]  G. B. Gori.  Adjudicating cancer causation: scientific, political, and legal conflicts. , 1991, Regulatory toxicology and pharmacology : RTP.

[10]  G. B. Gori.  Are animal tests relevant in cancer risk assessment? A persistent issue becomes uncomfortable. , 1991, Regulatory toxicology and pharmacology : RTP.

[11]  D. Lewis,et al.  The 1990 Pharmaceutical Manufacturers Association of Canada keynote lecture. The role of the cytochromes P450 in the detoxication and activation of drugs and other chemicals. , 1991, Canadian journal of physiology and pharmacology.

[12]  D. Lewis,et al.  A prospective toxicity evaluation (COMPACT) on 40 chemicals currently being tested by the National Toxicology Program. , 1990, Mutagenesis.

[13]  D. Parke,et al.  Effects of acute and sub-chronic administration of iron nitrilotriacetate in the rat. , 1989, Toxicology.

[14]  C. Ioannides,et al.  Metabolic Activation of Carcinogens and Toxic Chemicals , 1988, Human toxicology.

[15]  J. G. Vinter,et al.  Strategic approaches to drug design. I. An integrated software framework for molecular modelling , 1987, J. Comput. Aided Mol. Des..

[16]  D. Lewis,et al.  Molecular dimensions of the substrate binding site of cytochrome P-448. , 1986, Biochemical pharmacology.

[17]  M. Ingelman-Sundberg,et al.  On the significance of the cytochrome P-450-dependent hydroxyl radical-mediated oxygenation mechanism. , 1982, Xenobiotica; the fate of foreign compounds in biological systems.

[18]  J. Pople,et al.  Approximate Self-Consistent Molecular Orbital Theory. I. Invariant Procedures , 1965 .

[19]  C. Ioannides,et al.  Induction of cytochrome P4501 as an indicator of potential chemical carcinogenesis. , 1993, Drug metabolism reviews.

[20]  D. Lewis,et al.  Interaction of some peroxisome proliferators with the mouse liver peroxisome proliferator-activated receptor (PPAR): a molecular modelling and quantitative structure-activity relationship (QSAR) study. , 1993, Xenobiotica; the fate of foreign compounds in biological systems.

[21]  B. Halliwell,et al.  Role of free radicals and catalytic metal ions in human disease: an overview. , 1990, Methods in enzymology.

[22]  C. Ioannides,et al.  Role of cytochromes P-450 in mouse liver tumor production. , 1990, Progress in clinical and biological research.

[23]  C. Ioannides,et al.  The cytochrome P450 I gene family of microsomal hemoproteins and their role in the metabolic activation of chemicals. , 1990, Drug metabolism reviews.

[24]  C. Ioannides,et al.  Prediction of chemical carcinogenicity from molecular and electronic structures: a comparison of MINDO/3 and CNDO/2 molecular orbital methods. , 1989, Toxicology letters.

[25]  C. Ioannides,et al.  Molecular orbital studies of oxygen activation and mechanisms of cytochromes P-450-mediated oxidative metabolism of xenobiotics. , 1989, Chemico-biological interactions.

[26]  B. Ames.  Mutagenesis and carcinogenesis: Endogenous and exogenous factors , 1989, Environmental and molecular mutagenesis.

[27]  R. Tennant,et al.  Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP. , 1988, Mutation research.

[28]  C. Ioannides,et al.  Structural requirements for substrates of cytochromes P-450 and P-448. , 1987, Chemico-biological interactions.